Similar articles

• Preparation and absorption of antiserum against mouse L cell interferon.

  Dalton B, Paucker K. Dalton B, et al. Methods Enzymol. 1981;79(Pt B):582-5. doi: 10.1016/s0076-6879(81)79078-5. Methods Enzymol. 1981. PMID: 6173714 No abstract available.
• Antigenic properties of crossprotecting factors in human leukocyte and mouse L cell interferons.

  Paucker K, Dalton BJ. Paucker K, et al. Ann N Y Acad Sci. 1980;350:332-8. doi: 10.1111/j.1749-6632.1980.tb20632.x. Ann N Y Acad Sci. 1980. PMID: 6165285 No abstract available.
• Antigenic properties of murine interferons from cells of non-lymphoid origin.

  Havell EA, Spitalny GL. Havell EA, et al. Tex Rep Biol Med. 1981-1982;41:280-6. Tex Rep Biol Med. 1981. PMID: 6184814 No abstract available.
• Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.

  Pyhälä. Pyhälä. Acta Pathol Microbiol Scand C. 1978 Dec;86C(6):291-8. doi: 10.1111/j.1699-0463.1978.tb02593.x. Acta Pathol Microbiol Scand C. 1978. PMID: 726897
• Purification of human interferons by antibody affinity chromatography.

  Berg K, Alacam R, Hamilton RD, Heron I. Berg K, et al. Tex Rep Biol Med. 1977;35:187-92. Tex Rep Biol Med. 1977. PMID: 358447 Review.